Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant <i>Pseudomonas aeruginosa</i> and Minimize Biofilm Formation

Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant <i>Pseudomonas aeruginosa</i> and Minimize Biofilm Formation

The emergence of antibiotic resistance has severely impaired the treatment of chronic respiratory infections caused by multidrug-resistant (MDR) <i>Pseudomonas aeruginosa</i>. Since the reintroduction of polymyxins as a last-line therapy against MDR Gram-negative bacteria, resistance to...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Hasini Wickremasinghe, Heidi H. Yu, Mohammad A. K. Azad, Jinxin Zhao, Phillip J. Bergen, Tony Velkov, Qi Tony Zhou, Yan Zhu, Jian Li
Formaat: Artikel
Taal:English
Gepubliceerd in: MDPI AG 2021-04-01
Reeks:Antibiotics
Onderwerpen:
polymyxin
meropenem
combination therapy
multidrug resistance
<i>Pseudomonas aeruginosa</i>
synergy
Online toegang:https://www.mdpi.com/2079-6382/10/4/405

Internet

https://www.mdpi.com/2079-6382/10/4/405

Gelijkaardige items